Barclays’s Universal Health Services UHS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-78,200
| Closed | -$11.5M | – | 5023 |
|
|
2021
Q2 | $11.5M | Buy |
+78,200
| New | +$11.8M | 0.01% | 1147 |
|
|
2020
Q2 | – | Sell |
-900
| Closed | -$89K | – | 6261 |
|
|
2020
Q1 | $89K | Sell |
900
-100
| -10% | -$12.7K | ﹤0.01% | 4882 |
|
|
2019
Q4 | $143K | Sell |
1,000
-300
| -23% | -$42.8K | ﹤0.01% | 5268 |
|
|
2019
Q3 | $193K | Sell |
1,300
-3,700
| -74% | -$531K | ﹤0.01% | 4989 |
|
|
2019
Q2 | $652K | Buy |
5,000
+4,200
| +525% | +$529K | ﹤0.01% | 4094 |
|
|
2019
Q1 | $107K | Sell |
800
-33,500
| -98% | -$4.41M | ﹤0.01% | 5309 |
|
|
2018
Q4 | $4M | Buy |
34,300
+33,800
| +6,760% | +$4.25M | ﹤0.01% | 1760 |
|
|
2018
Q3 | $64K | Sell |
500
-15,900
| -97% | -$1.95M | ﹤0.01% | 5912 |
|
|
2018
Q2 | $1.83M | Buy |
16,400
+16,000
| +4,000% | +$1.87M | ﹤0.01% | 2656 |
|
|
2018
Q1 | $47K | Sell |
400
-3,300
| -89% | -$392K | ﹤0.01% | 5945 |
|
|
2017
Q4 | $419K | Sell |
3,700
-11,900
| -76% | -$1.27M | ﹤0.01% | 4033 |
|
|
2017
Q3 | $1.73M | Sell |
15,600
-200
| -1% | -$22.5K | ﹤0.01% | 2491 |
|
|
2017
Q2 | $1.93M | Buy |
15,800
+13,800
| +690% | +$1.64M | ﹤0.01% | 2280 |
|
|
2017
Q1 | $249K | Buy |
2,000
+500
| +33% | +$59.1K | ﹤0.01% | 4096 |
|
|
2016
Q4 | $160K | Buy |
1,500
+400
| +36% | +$47.4K | ﹤0.01% | 4396 |
|
|
2016
Q3 | $136K | Buy |
+1,100
| New | +$139K | ﹤0.01% | 4283 |
|
|
2016
Q2 | – | Sell |
-1,000
| Closed | -$124K | – | 6643 |
|
|
2016
Q1 | $124K | Sell |
1,000
-39,700
| -98% | -$4.46M | ﹤0.01% | 4203 |
|
|
2015
Q4 | $4.84M | Buy |
40,700
+36,700
| +918% | +$4.49M | 0.01% | 1342 |
|
|
2015
Q3 | $496K | Sell |
4,000
-8,500
| -68% | -$1.18M | ﹤0.01% | 3348 |
|
|
2015
Q2 | $1.77M | Buy |
12,500
+12,100
| +3,025% | +$1.52M | ﹤0.01% | 2325 |
|
|
2015
Q1 | $47K | Hold |
400
| – | – | ﹤0.01% | 5327 |
|
|
2014
Q4 | $44K | Sell |
400
-3,900
| -91% | -$410K | ﹤0.01% | 5825 |
|
|
2014
Q3 | $447K | Sell |
4,300
-5,800
| -57% | -$616K | ﹤0.01% | 4041 |
|
|
2014
Q2 | $960K | Buy |
10,100
+8,900
| +742% | +$769K | ﹤0.01% | 3379 |
|
|
2014
Q1 | $98K | Sell |
1,200
-166,500
| -99% | -$13.4M | ﹤0.01% | 5477 |
|
|
2013
Q4 | $13.6M | Buy |
167,700
+300
| +0.2% | +$24K | 0.01% | 1032 |
|
|
2013
Q3 | $12.4M | Buy |
167,400
+84,300
| +101% | +$5.88M | 0.01% | 987 |
|
|
2013
Q2 | $5.57M | Buy |
+83,100
| New | +$5.49M | 0.01% | 1536 |
|
Other funds holding UHS
VCM
VPM
Barclays's UHS Position: Q1 2026 in Review
Barclays increased its Universal Health Services (UHS) stake by 5.9% in Q1 2026, buying an estimated $1.52M and bringing the position to 132,553 shares worth $23.7M. The position accounts for 0.01% of the portfolio, ranked #1023.
Barclays first reported a position in UHS in Q2 2013 and has held it in 52 quarters since. The position peaked at $43.2M in Q3 2024. 652 funds tracked by Wall St. Rank hold UHS as of Q1 2026.
- Barclays held 132,553 shares of Universal Health Services worth $23.7M as of Q1 2026.
- Barclays bought 7,382 Universal Health Services shares in Q1 2026, an estimated $1.52M.
- Universal Health Services made up 0.01% of Barclays's portfolio in Q1 2026, its #1023 holding.
- Barclays first reported a position in Universal Health Services in Q2 2013 and has held it in 52 quarters since.
- Barclays's Universal Health Services position peaked at $43.2M in Q3 2024.
- 652 funds tracked by Wall St. Rank held Universal Health Services as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.